Abstract Background and aims Atrial fibrillation or flutter is a major stroke risk factor requiring anticoagulation when detected. These arrhythmias can be intermittent, making diagnosis challenging. Traditionally, Holter monitors were used, requiring technician fitting and cardiology review. Recently, our service introduced CardioScan wearable monitors patch-based devices analysed externally, with reports sent directly to stroke physicians. To evaluate the impact of introducing CardioScan wearable cardiac monitors compared to traditional Holter monitoring in stroke patients, focusing on timeliness, workflow efficiency, and arrhythmia detection. Methods compared two monitoring strategies within our Acute Stroke Unit Data were collected on: Audit data were extracted from patient records over a defined period following implementation of the CardioScan service. Results CardioScan monitors enabled significantly earlier initiation of cardiac monitoring compared to Holter devices, reducing delays caused by technician availability and device return. Both methods provided approximately 72 hours of monitoring; however, CardioScan offered greater flexibility in fitting and minimized logistical challenges. AF detection rates were comparable between the two approaches. Conclusions Introducing CardioScan wearable monitors improved the timeliness and efficiency of cardiac monitoring in stroke patients, reducing delays and simplifying workflow compared to traditional Holter monitoring. While AF detection rates were similar, the streamlined process and faster turnaround may enhance patient care and facilitate earlier initiation of anticoagulation therapy. Further evaluation is warranted to assess long-term outcomes and cost-effectiveness. Conflict of interest kavulu sarah senganda nothing to disclose
Senganda et al. (Fri,) studied this question.